Variant report
Variant | nsv874022 |
---|---|
Chromosome Location | chr2:49641706-49662078 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187659809 | chr2:49649260-49649261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541618776 | chr2:49649300-49649301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560024519 | chr2:49649312-49649313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1527914 | chr2:49649313-49649314 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs1365856 | chr2:49649326-49649327 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs569509217 | chr2:49649329-49649330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538988588 | chr2:49649334-49649335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371603347 | chr2:49649388-49649389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530514691 | chr2:49649396-49649397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112675275 | chr2:49649402-49649403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377026287 | chr2:49649421-49649422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1365857 | chr2:49649433-49649434 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs553154033 | chr2:49649482-49649483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs367648434 | chr2:49649490-49649491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs817005 | chr2:49649517-49649518 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs12616235 | chr2:49649560-49649561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144713905 | chr2:49649567-49649568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375130638 | chr2:49653601-49653602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533143868 | chr2:49653629-49653630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540238994 | chr2:49653660-49653661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12105450 | chr2:49653672-49653673 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs185186678 | chr2:49653673-49653674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529407271 | chr2:49653680-49653681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577526583 | chr2:49653690-49653691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs386645914 | chr2:49653700-49653701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569414302 | chr2:49653704-49653705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115639765 | chr2:49653707-49653708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28391115 | chr2:49653709-49653710 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs17038785 | chr2:49653746-49653747 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs530602291 | chr2:49653759-49653760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551871316 | chr2:49653776-49653777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs67353038 | chr2:49653789-49653790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188427197 | chr2:49653801-49653802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181189490 | chr2:49653819-49653820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146892545 | chr2:49653842-49653843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112773722 | chr2:49653848-49653849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559750722 | chr2:49653901-49653902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530049324 | chr2:49653909-49653910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140784234 | chr2:49653913-49653914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569633674 | chr2:49653925-49653926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144577805 | chr2:49653959-49653960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559077262 | chr2:49653960-49653961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1527886 | chr2:49653980-49653981 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs541638407 | chr2:49654020-49654021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553026248 | chr2:49654023-49654024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185888147 | chr2:49654072-49654073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566538548 | chr2:49654075-49654076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191545228 | chr2:49654082-49654083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369554642 | chr2:49654091-49654092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181634868 | chr2:49654131-49654132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49649200-49649600 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr2:49653600-49654600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:49654000-49654400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr2:49654000-49655000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr2:49654000-49655200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:49654200-49655000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |